R. Ferszt

R. Ferszt

Auto-generated profile, based on publicly available information

R. Ferszt

Department of Gerontopsychiatry, Freie Universität Berlin, Germany

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1996
Verified
Journal Article
Closed access
LBLiv Bode
Liv Bode
RDR Dürrwald
R Dürrwald
FRFedik Abdul Rantam
Fedik Abdul Rantam
RFR Ferszt
R Ferszt
HLH Ludwig
H Ludwig

1 July 1999 in Pharmacopsychiatry
Verified
Journal Article
Closed access
PDF file
RFR. Ferszt
R. Ferszt
KKK.-P. Kühl
K.-P. Kühl
LBLiv Bode
Liv Bode
ESE. W. Severus
E. W. Severus
BWB. Winzer
B. Winzer
HLH. Ludwig
H. Ludwig
Amantadinesulfate is a well known substance which has proven useful in the treatment and prophylaxis of viral infections, in treating symptoms of Parkinson's disease, cocaine dependence, and apathy in multiple sclerosis. It has also been reported as having mild antidepressive effects not sufficient to warrant its use as an antidepressant. Striking antidepressive effects in some patients have been attributed to its antiviral activity against human Borna disease virus (BDV) infection which is frequently seen in patients with depressive episodes. In this 8 to 12 week open study of oral amantadine in 30 depressed patients with various states of BDV infection we found a significant antidepressive response in 19 of 30. Peripheral BDV antigen indicating acute infection was cleared in both responders and non-responders, but only in responders peripheral infection was significantly reduced.

1 May 1999 in Pharmacopsychiatry
Verified
Journal Article
Closed access
PDF file
RFR. Ferszt
R. Ferszt
ESE. Severus
E. Severus
LBLiv Bode
Liv Bode
MBM. Brehm
M. Brehm
KKK.-P. Kühl
K.-P. Kühl
HLH. Ludwig
H. Ludwig
Background: Borna disease virus (BDV) is an animal pathogen that causes behavioral changes in animals. Previous studies have found a high prevalence of serum antibodies as well as Borna disease viral antigens (BDVAGs) and RNA in the white blood cells of psychiatric patients, especially those with affective disorders. The present study attempts to offer a better description of the BDVAG cohort using clinical parameters. Methods: The prevalence of BDVAG was examined in the peripheral mononuclear leukocytes of patients with a major depressive episode. A subgroup of patients underwent further clinical analysis. Results: In this pilot study, at least, there was a significant difference in the prevalence of BDVAG between psychiatric inpatients with a major depressive episode and control individuals. It also appeared that BDVAG is more frequent in patients with recurrent major depression or bipolar disorder than in those with any other psychiatric disorder studied. The number of previous depressive episodes, as well as symptoms involving fatigue and concentration difficulties were positively related to BDVAG. Conclusions: The high rate of BDVAG, especially in fatigued patients with recurrent major depression or bipolar disorder, may be a nonspecific aspect of immunosuppression. The question remains whether this neurotropic virus may contribute to the pathogenesis of some types of affective disorder.

1 May 1998 in Pharmacopsychiatry
Verified
Journal Article
Closed access
RFR. Ferszt
R. Ferszt
ESE. Severus
E. Severus